Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPANXN3 is a testis-expressed protein and member of the SPANX-N subfamily on the X chromosome. It shows restricted expression mainly in post-meiotic spermatids, the acrosome region of sperm, and at low levels in selected cancers such as melanoma. It is part of the broader SPANX family of cancer/testis antigens that can be aberrantly expressed in tumors and considered for immunotherapy strategies. The protein is small, contains conserved functional motifs, and possibly has a role in nuclear organization and chromatin structure in sperm, with potential functional diversification in cancers. There are no reported drugs targeting SPANXN3 directly, and its biomarker or safety profile is uncertain due to limited clinical studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm protein associated with the nucleus on the X chromosome N3 (SPANXN3).